Babalı et al. [12] found that patients with NAFLD had higher AFP levels, and suggested that hepatic inflammation, regeneration and/or fibrosis may be responsible for the elevation of serum AFP levels in patients with severe fatty liver. This evidence concerns the gene AFP and metabolic dysfunction-associated steatotic liver disease.